Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 7 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

29%

2 trials in Phase 3/4

Results Transparency

0 of 2 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A

2(40.0%)

Phase 4

1(20.0%)

Phase 1

1(20.0%)

Phase 3

1(20.0%)

5Total

N/A(2)

Phase 4(1)

Phase 1(1)

Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (7)

Showing 7 of 7 trials

NCT07491094Not Yet Recruiting

Repeated Examinations for Typing Pulmonary Embolism

Role: collaborator

NCT07274306Active Not Recruiting

Incidence, Treatment and Outcome After Acute Mesenteric Ischemia in the Region of Västra Götaland, 2000-2023.

Role: collaborator

NCT03560310Phase 4Active Not Recruiting

Ticagrelor and ASA vs. ASA Only After Isolated Coronary Artery Bypass Grafting in Patients With Acute Coronary Syndrome

Role: collaborator

NCT03017326Phase 3Active Not Recruiting

Paediatric Hepatic International Tumour Trial

Role: collaborator

NCT06310798Not ApplicableNot Yet Recruiting

Inter-organizational Health Planning for Older Adults: Public Dental Care and Municipal Care

Role: collaborator

NCT06005376Not ApplicableCompleted

Development of a Celiac Safe Food Additive

Role: collaborator

NCT03441412Phase 1Completed

A Study of the Effect of Epinephrine on Platelet Reactivity in Subjects Treated With Ticagrelor

Role: collaborator

All 7 trials loaded